SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness
Open Access
- 17 August 2020
- preprint content
- other
- Published by Cold Spring Harbor Laboratory
Abstract
SARS-CoV-2-specific antibodies, particularly those preventing viral spike receptor binding domain (RBD) interaction with host angiotensin-converting enzyme 2 (ACE2) receptor, could offer protective immunity, and may affect clinical outcomes of COVID-19 patients. We analyzed 625 serial plasma samples from 40 hospitalized COVID-19 patients and 170 SARS-CoV-2-infected outpatients and asymptomatic individuals. Severely ill patients developed significantly higher SARS-CoV-2-specific antibody responses than outpatients and asymptomatic individuals. The development of plasma antibodies was correlated with decreases in viral RNAemia, consistent with potential humoral immune clearance of virus. Using a novel competition ELISA, we detected antibodies blocking RBD-ACE2 interactions in 68% of inpatients and 40% of outpatients tested. Cross-reactive antibodies recognizing SARS-CoV RBD were found almost exclusively in hospitalized patients. Outpatient and asymptomatic individuals’ serological responses to SARS-CoV-2 decreased within 2 months, suggesting that humoral protection may be short-lived.Keywords
This publication has 30 references indexed in Scilit:
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformationScience, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance, 2020
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibodyEmerging Microbes & Infections, 2019
- Myeloid immunosuppression and immune checkpoints in the tumor microenvironmentCellular & Molecular Immunology, 2019
- Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus InfectionsEmerging Infectious Diseases, 2019
- Structure, Function, and Evolution of Coronavirus Spike ProteinsAnnual Review of Virology, 2016
- Antibody Response and Disease Severity in Healthcare Worker MERS SurvivorsEmerging Infectious Diseases, 2016
- Transmission of MERS-Coronavirus in Household ContactsThe New England Journal of Medicine, 2014